Spruce Biosciences, Inc.

SPRBNASDAQHealthcareBiotechnology

$39.65- (-)1Y −73.72%

As of Oct 16, 2026 close

Market cap: $100.82M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $38.06$179.95
Volume (live): -
Avg. volume (3M): 94.75K

Spruce Biosciences, Inc. (SPRB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Spruce Biosciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy

Based on 5 unique analysts

Medium Confidence∞:1 Buy/Sell

Average Price Target

$154.60

+289.91% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest SPRB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 30, 2026	Albert Lowe	Craig-Hallum	Maintains	Buy	$140.00
Sep 17, 2026	Daniel Brims	Lake Street	Initiates	Buy	$149.00
Aug 26, 2026	Ram Selvaraju	HC Wainwright	Reiterates	Buy	$150.00
Aug 25, 2026	Leland Gershell	Oppenheimer	Reiterates	Buy	$230.00
Aug 17, 2026	Debjit Chattopadhyay	Guggenheim	Maintains	Buy	$123.00 → $104.00 −19.00 (−15.4%)

Albert Lowe

Craig-Hallum

BuyMaintains

$140.00

Sep 30

Daniel Brims

Lake Street

BuyInitiates

$149.00

Sep 17

Ram Selvaraju

HC Wainwright

BuyReiterates

$150.00

Aug 26

Leland Gershell

Oppenheimer

BuyReiterates

$230.00

Aug 25

Debjit Chattopadhyay

Guggenheim

BuyMaintains

$123.00 → $104.00

Aug 17

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for SPRB?

The analyst consensus rating for SPRB is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for SPRB?

The average 12-month price target for SPRB is $154.60, representing an upside of 289.9% from the Oct 16, 2026 close of $39.65.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.